Financial reports
Current reports
6-K
Share Purchase and Sale Agreement
20 Sep 24
6-K
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
13 Sep 24
6-K
Current report (foreign)
5 Sep 24
6-K
Current report (foreign)
30 Aug 24
6-K
Current report (foreign)
20 Aug 24
6-K
Common Stock Purchase Agreement
31 Jul 24
6-K
Current report (foreign)
24 Jul 24
6-K
Current report (foreign)
23 Jul 24
6-K
Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
5 Jul 24
6-K
Current report (foreign)
20 Jun 24
Registration and prospectus
424B3
Prospectus supplement
30 Aug 24
F-1
Registration statement (foreign)
19 Aug 24
424B3
Prospectus supplement
19 Aug 24
POS AM
Prospectus update (post-effective amendment)
12 Aug 24
S-8
Registration of securities for employees
30 Jul 24
F-1/A
Registration statement (foreign) (amended)
6 May 24
F-1/A
Registration statement (foreign) (amended)
18 Apr 24
F-1
Registration statement (foreign)
9 Feb 24
8-A12B
Registration of securities on exchange
25 Jan 24
425
Business combination disclosure
22 Jan 24
Proxies
No filings
Other
EFFECT
Notice of effectiveness
29 Aug 24
EFFECT
Notice of effectiveness
16 Aug 24
EFFECT
Notice of effectiveness
15 May 24
CERT
Certification of approval for exchange listing
26 Jan 24
SEC STAFF
SEC staff action: Order
15 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
EFFECT
Notice of effectiveness
13 Nov 23
CORRESP
Correspondence with SEC
3 Nov 23
UPLOAD
Letter from SEC
25 Oct 23
CORRESP
Correspondence with SEC
16 Oct 23